Shareholders in Bioglan Pharma have approved the acquisition of a range of dermatological products from Medicis Pharmaceutical Corp. At an e.g.m. yesterday, they also approved a placing and open offer to finance the acquisition. The results of the offer will be announced on July 21st.
Bioglan e.g.m. backs purchase
Shareholders in Bioglan Pharma have approved the acquisition of a range of dermatological products from Medicis Pharmaceutical…
IN THIS SECTION
High Court suspends solicitor over ‘serious and extensive’ record-keeping failures
Macron names centrist ally Francois Bayrou as new French prime minister
High Court upholds refusal to restore registration of botox and weight loss doctor deemed unfit to practise
Millions in Ukraine without power after another massive Russian attack on energy grid
Felix Jones free to work with club team or Tier 2 nation after England departure
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning